Skip to Content

Case Overview

57 Days Left to Seek Lead Plaintiff
Lead Plaintiff Deadline: Lead Plaintiff Deadline: 03/13/2026
Status: Status: Investigating
Company Name: Company Name: Coreweave, Inc.
Court: Court: District of New Jersey
Case Number: Case Number: 2:26cv00355
Class Period: Class Period: 03/28/2025 - 12/15/2025
Ticker: Ticker: CRWV
Related Attorneys: Lead Attorneys: Thomas W. Elrod
Related Practices: Related Practices: Securities

CoreWeave purports to be an artificial intelligence ("AI") cloud computing company and self-described "Hyperscaler", which its Prospectus (defined below) defined as "a cloud provider or technology company that is capable of delivering computing infrastructure and services at massive scale, typically through large data centers and geographically distributed networks." CoreWeave purports to generate substantially all of its revenue from committed long-term contracts providing customers with access to its AI infrastructure and proprietary managed software and application services through CoreWeave Cloud Platform (the "Cloud Platform"). CoreWeave recognizes revenue from such contracts only once it completes installation of the infrastructure necessary to provide its customers with access to the Cloud Platform, including the data centers that house the hardware on which its proprietary software runs. Such data centers are also known as "powered shells." After executing a committed contract and receiving a prepayment from its customer, CoreWeave purchases infrastructure components and installs systems necessary to provide its contracted services. Only after the necessary system infrastructure installation is complete and a contract goes live does CoreWeave recognize revenue from the contract. CoreWeave's Cloud Platform is hosted in its distributed network of active purpose-built data centers. Without these underlying data centers, CoreWeave is unable to sell its services to customers or recognize revenue from committed long-term contracts for its services. On March 10, 2025, less than three weeks before CoreWeave conducted its initial public offering ("IPO"), the Company announced a deal worth up to $11.9 billion to deliver AI infrastructure to Open AI, a leading AI company. This announcement served only to bolster investors' anticipation of CoreWeave's IPO. On March 28, 2025, CoreWeave conducted its IPO, selling 37.5 million shares of common stock priced at $40.00 per share and raising $1.5 billion (the "Prospectus"). On March 31, 2025, CoreWeave filed a prospectus on Form 424B4 with the United States Securities and Exchange Commission in connection with the IPO. In the months following CoreWeave's IPO, its stock price skyrocketed to prices as high as $183.58 on June 20, 2025, a 348.95% increase from the offering price. During this time the Defendants consistently represented to investors that the demand for CoreWeave's services was "robust" and "unprecedented," and made positive revenue forecasts in part due to this demand. However, constantly looming over CoreWeave was the question of how it could meet this "robust" and "unprecedented" customer demand, given the limitations on the infrastructure underlying its AI services. The data centers necessary to CoreWeave's Cloud Platform are highly specialized and in certain cases, designed to meet a customer's bespoke needs. The limitations referenced above arise because only a limited number of suppliers provide the components and materials necessary to construct these specialized data centers and their contents. Nevertheless, CoreWeave consistently issued positive revenue guidance during the Class Period-even raising its guidance on one occasion, as discussed infra at 55)- while steadily assuring investors that it was equipped to capitalize on the high customer demand for its AI services. On July 7, 2025, CoreWeave announced a definitive agreement to acquire Core Scientific, Inc. ("Core Scientific"), one of the largest owners and operators of digital infrastructure for high performance computing in North America, in an all-stock transaction (the "Core Scientific Acquisition"). In its announcement, the Company quoted CoreWeave's Co-Founder and Chief Executive Officer, Defendant Michael Intrator, as stating the Core Scientific Acquisition enabled CoreWeave to "significantly enhance operating efficiency and de-risk our future expansion, solidifying our growth trajectory." The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) Defendants had overstated CoreWeave's ability to meet customer demand for its service; (ii) Defendants materially understated the scope and severity of the risk that CoreWeave's reliance on a single third-party data center supplier presented for CoreWeave's ability to meet customer demand for its services; (iii) the foregoing was reasonably likely to have a material negative impact on the Company's revenue; (iv) as a result, the Company's public statements were materially false and misleading at all relevant times. During market hours on October 30, 2025, Core Scientific announced it had not received enough shareholder votes to approve its merger agreement with CoreWeave and, as a result, terminated the merger agreement. On this news, CoreWeave's stock price fell $8.87 per share, or 6.33%, to close at $131.06 per share on October 30, 2025. Then, after market hours on November 10, 2025, CoreWeave issued a press release reporting its financial results for quarter ended September 30, 2025. Also on November 10, 2025, CoreWeave held a conference call concerning its financial results for the quarter ended September 30, 2025 (the "Q3 2025 Earnings Call"). During the Q3 2025 Earnings Call, Defendants announced lowered revenue guidance for 2025, citing "delays related to a third-party data center developer who is behind schedule." Then, during market hours on November 11, 2025, Defendant Intrator appeared for an interview on CNBC's "Squawk on the Street," hosted by Jim Cramer (the "CNBC Interview"). During the CNBC Interview, after Cramer challenged his initial characterization of the delays at issue, Defendant Intrator conceded that the delays implicated not just one data center, but a single data center provider-i.e., that more than one data center owned by the same provider was potentially affected. On this news, CoreWeave's stock price fell $17.22 per share, or 16.31%, to close at $88.30 per share on November 11, 2025. Then, after market hours on December 15, 2025, the Wall Street Journal published an article reporting new information concerning the data center provider delays, revealing that the scope and severity of data center delivery issues were greater than Defendants acknowledged during the Q3 2025 Earnings Call and the CNBC Interview. The article revealed that weather-related delays would push back the completion date of a Denton, Texas data center cluster intended for OpenAI by several months, that other data centers would be delayed due to revised design plans, that Core Scientific was CoreWeave's building partner behind the delayed data centers, and that Core Scientific began flagging these delays nine months beforeCoreWeave announced lowered revenue guidance in November 2025. On this news, CoreWeave's stock price fell $2.85 per share, or 3.39%, to close at $69.50 per share on December 16, 2025.

Frequently Asked Questions*

  • A.A class action is a lawsuit in which a large number of people (the “class”) have suffered similar harm from the defendant(s)’ unlawful conduct and the plaintiff(s), also known as the “class representative,” stands in for the entire group of similarly injured persons for the duration of the lawsuit and prosecutes the lawsuit on behalf of the entire class. As such, any result obtained by the class representative in the class action lawsuit applies to all of the members of the class. Class action lawsuits are an efficient legal procedure when it would be impractical or expensive for each similarly harmed individual in the class to file their own lawsuit. Class actions enable shareholders to seek recovery from defendant corporations that have much greater resources without having to bear the financial risk.
  • A.Securities class action lawsuits typically allege that defendant(s), typically corporations that issue publicly-traded securities and their officers, misrepresented or concealed material information, which caused the securities to trade at artificially inflated prices when class members purchased the securities. The class members suffer losses when the previously-concealed information is disclosed, and the price of the securities declines. These actions charge the defendants with violations of the Securities Act of 1933 and/or the anti-fraud provisions of the Securities Exchange Act of 1934.
  • A.A class period is a specified time period during which the injury to the class is alleged to have occurred. In a securities class action, this is the period during which the securities in question traded at artificially inflated prices as a result of the misrepresentations or omissions complained of. The class period proposed in a securities fraud class action may change during the course of the litigation as a result of new evidence obtained or rulings by the court.
  • A.A typical securities class action often takes several years to litigate. The actual time it takes to resolve a specific case varies, depending on the complexity of the case, the issues involved, the procedural stage at which the suit is resolved, and other factors.
  • A.The lead plaintiff is the investor that prosecutes the suit on behalf of the other investors. This plaintiff eventually seeks to be appointed as the class representative of the class. Federal securities laws permit any investor who purchased or acquired the covered securities during the class period to seek appointment as lead plaintiff of a securities class action lawsuit within sixty (60) days of the first press release announcing the first filed securities class action. An individual investor, an institutional investor, or groups of investors can seek to be appointed as lead plaintiff.

    Courts generally appoint as lead plaintiff the movant(s) with the greatest financial interest in the relief sought by the proposed class. The lead plaintiff generally can select a law firm of its choice to litigate the securities class action lawsuit as lead counsel for the class. Courts generally appoint the lead plaintiffs’ chosen law firm as lead counsel.
  • A.If you are interested in seeking lead plaintiff appointment, you can contact Kirby McInerney via email at investigations@kmllp.com or submit a contact form via the firm’s website. Critically, the decision to seek lead plaintiff appointment is time sensitive. Class members have sixty (60) days after a securities fraud class action lawsuit is filed to request the court for appointment as lead plaintiff.
  • A.If you have incurred a substantial loss as a result of purchasing the securities covered by a securities class action, acting as a lead plaintiff provides you an opportunity to take an active role in the litigation of the case and to represent the shareholders in the class. The lead plaintiff must stay apprised of the litigation by overseeing court-appointed lead counsel and remaining informed about the progress of the litigation. If the litigation advances into discovery, the lead plaintiff will be required to participate in discovery and potentially provide documents and testimony relating to the investment in question. You will be able to participate in making critical decisions regarding the litigation, including whether to settle the action and at what amount, and the formula to be used in determining how any settlement proceeds are divided among class members.

    An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the securities class action lawsuit. The lead plaintiff is entitled to receive a pro rata share of any classwide settlement or trial recovery. However, as provided for by the Private Securities Litigation Reform Act of 1995, the court will sometimes compensate the lead plaintiff with an additional monetary award for their time and efforts in overseeing the case.
  • A.Any person who purchased the security at issue during the class period is eligible to participate. The attorneys at Kirby McInerney can quickly investigate the facts and advise you on your potential claim, as a lead plaintiff or a class member. Your rights are the same whether you later sold at a loss or have held some or all of your shares in the hope that the price will recover.
  • A.If you do not want to be lead plaintiff, you do not need to take any action at the outset of the litigation in order to participate in the class action as you may remain an absent class member. In the event that the lawsuit is certified by the court as a class action, all members of the class will receive mailed notice informing them of the steps that they will need to take in order to share in any classwide recovery.
  • A.If you are a member of the class, at the point of a classwide settlement or trial recovery, a court-appointed administrator will mail out notifications to class members relating to your claim and the case status. Because securities class actions often take several years, you should be sure to retain your records so that you can provide documentation of your purchases in the event of a settlement or trial recovery.
  • A.To participate in a securities class action, you generally are not required to continue to hold shares of the company after the class period expires. Your standing to participate in the securities class action is derived from your purchase and/or acquisition of shares during the alleged class period. But your decision to sell or otherwise dispose of securities following the class period may impact your damages. Likewise, selling your securities potentially limits your ability to assert other types of claims, including but not limited to shareholder derivative claims.
  • A.Kirby McInerney litigates its class action cases on a contingency fee basis. This means we only get paid if we win the case at trial or if there is a settlement. The Firm does not receive any form of monetary compensation from a client at the outset of litigation or if the lawsuit is unsuccessful in recovering money for investors. Instead, the Firm’s fees are paid out of the recovery if there is a successful resolution to the case and a settlement or judgment is achieved. Attorneys’ fees may vary based on the size of the recovery, the duration and complexity of the litigation, and other factors. Kirby McInerney also generally advances all out-of-pocket costs and court expenses on behalf of its clients. Attorneys’ fees and expense reimbursement requests are subject to court approval. This system helps ensure that many investors with small losses can easily afford to bring class actions to assert their rights.
  • A.Generally, no. Your out-of-pocket losses usually will be greater than recoverable damages. Recoverable damages are affected by the time you purchased and sold your shares, the price of the stock after the class period, and other individual circumstances. Usually, class members are awarded damages that are proportional to the actual individualized harm they suffered.
  • A.As a small investor, if you purchased securities covered by a securities class action during the class period, your rights may already be protected by other investors with more significant losses who have already filed a securities class action. Kirby McInerney’s attorneys are available if you have any further questions about your rights as an investor.

* These "Frequently Asked Questions" are provided by Kirby McInerney LLP for educational and informational purposes only and is not intended and should not be construed as legal advice.

Contact Us About This Case

You may share a link to this page on any of the sites listed below or send link via email:

This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Privacy Policy.

Accept & Hide Message